Clearly, Nuke661, SK has been focusing our attention on the liver trial for years. I'd like to think he was doing this, because he thinks he can deliver a partnered Phase III liver study.
I too noticed the linking of clinical trial data with the preclinical data. Very promising indeed.
It was almost showmanship the way they referred to dozens of collaborations of Bavi with every other anti-cancer modality in the book - vaccines, radiation, etc. They also pointed out how these collaborations could lead to more serious relationships.
We are looking at a very promising situation. Just a few more steps and we will finally see the SP moving up. A lot.
GLTA, Paul
News 
Market Data 
Discover 
